Polymerase chain reaction (PCR) tests reveal infectiousness of hepatitis C
This article was originally published in Clinica
Executive Summary
Polymerase chain reaction tests for hepatitis C RNA can be used to tell whether people who are antibody-positive for the disease are likely to be pass it on, Australian researchers have found. The ability to detect infectiousness could help in counselling those exposed to hepatitis C virus (HCV) about the risk of transmission, report Dr Gregory Dore and colleagues in the August 9 issue of the British Medical Journal (Vol 315; pp 333-337).
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.